Arrivillaga Robert, Enrique Alejandro – Trademark Portfolio
Entity Type: 01
Arrivillaga Robert, Enrique Alejandro holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include KIFFER LABORATORIES. The owner is based in Santiago de Chile.
Providencia
General Holley N° 2366
Santiago de Chile 7500000 , CL
Showing of trademarks Trademarks
Trademark Classifications
Arrivillaga Robert, Enrique Alejandro's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Arrivillaga Robert, Enrique Alejandro have?
Arrivillaga Robert, Enrique Alejandro has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Arrivillaga Robert, Enrique Alejandro file in?
Arrivillaga Robert, Enrique Alejandro files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Arrivillaga Robert, Enrique Alejandro's most well-known trademarks?
Arrivillaga Robert, Enrique Alejandro's registered trademark portfolio includes well-known marks such as KIFFER LABORATORIES. These are among 2 currently registered trademarks in the portfolio.
What is Arrivillaga Robert, Enrique Alejandro's trademark registration success rate?
Arrivillaga Robert, Enrique Alejandro has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.